0.1419
price up icon0.07%   0.000100
after-market Handel nachbörslich: .14 -0.0019 -1.34%
loading

Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten

pulisher
07:55 AM

Tonix Pharma Partners for Vaccine Clinical Trial - Yahoo Finance

07:55 AM
pulisher
Nov 04, 2024

Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya - Yahoo Finance

Nov 04, 2024
pulisher
Nov 04, 2024

Tonix Pharmaceuticals Holding Corp. Announces Research Agreement with Kenya Medical Research Institute to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya - Marketscreener.com

Nov 04, 2024
pulisher
Nov 02, 2024

Tonix Pharmaceuticals (TNXP) Earnings Date and Reports 2024 - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

Tonix reports promising mpox vaccine candidate data By Investing.com - Investing.com South Africa

Nov 01, 2024
pulisher
Nov 01, 2024

Tonix reports promising mpox vaccine candidate data - Investing.com

Nov 01, 2024
pulisher
Nov 01, 2024

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024 - The Manila Times

Nov 01, 2024
pulisher
Oct 29, 2024

Tonix Pharmaceuticals CEO Discusses New Drug Application for Fibromyalgia Treatment - Proactive Investors UK

Oct 29, 2024
pulisher
Oct 29, 2024

Tonix Pharmaceuticals Holding (LTS:0A4T) PE Ratio (TTM) : At Loss (As of Oct. 29, 2024) - GuruFocus.com

Oct 29, 2024
pulisher
Oct 29, 2024

Tonix Pharmaceuticals to Present at BIO-Europe® 2024 - Yahoo Finance

Oct 29, 2024
pulisher
Oct 25, 2024

Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference - StockTitan

Oct 25, 2024
pulisher
Oct 24, 2024

Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe 2024 - Yahoo Finance

Oct 24, 2024
pulisher
Oct 17, 2024

TNXPTonix Pharmaceuticals Holding Corp. Latest Stock News & Market Updates - StockTitan

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharmaceuticals Holding (FRA:TPM0) Purchase Of Proper - GuruFocus.com

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharma gets DoD contract for antiviral development - Investing.com

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharma Secures Defense Contract for Antiviral Development - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharma gets DoD contract for antiviral development By Investing.com - Investing.com UK

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency (DTRA) - The Manila Times

Oct 17, 2024
pulisher
Oct 17, 2024

Tonix Pharmaceuticals Receives First Contract Payment from U.S. Department of Defense for Accelerated Development of Broad-Spectrum Antivirals with the Defense Threat Reduction Agency - Marketscreener.com

Oct 17, 2024
pulisher
Oct 16, 2024

Empery Asset Management LP Acquires Shares in Tonix Pharmaceuticals - Yahoo Finance

Oct 16, 2024
pulisher
Oct 16, 2024

Tonix Pharmaceuticals files NDA for fibromyalgia drug - Investing.com

Oct 16, 2024
pulisher
Oct 16, 2024

Tonix Pharmaceuticals files NDA for fibromyalgia drug By Investing.com - Investing.com UK

Oct 16, 2024
pulisher
Oct 16, 2024

Tonix Pharmaceuticals Announces Submission of the TNX-102 SL New Drug Application (NDA) for Fibromyalgia to the U.S. Food and Drug Administration (FDA) - Yahoo Finance

Oct 16, 2024
pulisher
Oct 10, 2024

Tonix Pharmaceuticals Partners with X-Chem for AI-Driven Antiviral Development - MSN

Oct 10, 2024
pulisher
Oct 09, 2024

Tonix and X-Chem collaborate to accelerate broad-spectrum antiviral development - BioWorld Online

Oct 09, 2024
pulisher
Oct 09, 2024

Tonix Pharma Enhances Drug Development with AI Partnership - Yahoo Finance

Oct 09, 2024
pulisher
Oct 08, 2024

Tonix secures DoD contract for antiviral drug development By Investing.com - Investing.com South Africa

Oct 08, 2024
pulisher
Oct 08, 2024

Tonix secures DoD contract for antiviral drug development - Investing.com

Oct 08, 2024
pulisher
Oct 08, 2024

Why Tonix Pharmaceuticals (TNXP) Stock Is Moving - Benzinga

Oct 08, 2024
pulisher
Oct 08, 2024

Tonix Pharmaceuticals Presents Promising Data on Fibromyalgia Treatment at Global Conference - Proactive Investors USA

Oct 08, 2024
pulisher
Oct 08, 2024

Tonix Pharmaceuticals Announces AI Collaboration with X-Chem to Develop Broad-Spectrum Antivirals - Yahoo Finance

Oct 08, 2024
pulisher
Oct 04, 2024

Tonix Pharm stock hits 52-week low at $0.13 amid steep decline By Investing.com - Investing.com South Africa

Oct 04, 2024
pulisher
Oct 04, 2024

StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - Defense World

Oct 04, 2024
pulisher
Oct 03, 2024

Tonix Pharm stock hits 52-week low at $0.13 amid steep decline - Investing.com Australia

Oct 03, 2024
pulisher
Oct 01, 2024

The Rush for Non-Addictive Painkillers to Counter the Opioid Crisis Puts Two Companies Close to FDA Decisions - PharmiWeb.com

Oct 01, 2024
pulisher
Sep 30, 2024

Tonix Pharmaceuticals Announces Participation in Endpoints Panel at the Long COVID Workshop and RECOVER TLC Workshop Convened by the Foundation for the National Institutes of Health (FNIH) and the National Institute of Allergy and Infectious Disea - Yahoo Finance

Sep 30, 2024
pulisher
Sep 28, 2024

What's Going On With Tonix Pharmaceuticals Stock Friday? - MSN

Sep 28, 2024
pulisher
Sep 27, 2024

Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 27, 2024

Tonix secures patent for migraine treatment into 2036 By Investing.com - Investing.com Canada

Sep 27, 2024
pulisher
Sep 27, 2024

Tonix Pharma Secures Patent, Bolsters Migraine Treatment Future - TipRanks

Sep 27, 2024
pulisher
Sep 27, 2024

Tonix secures patent for migraine treatment into 2036 - Investing.com

Sep 27, 2024
pulisher
Sep 27, 2024

Tonix Pharmaceuticals Announces Issuance of U.S. Patent Covering the Subcutaneous Delivery of FDA-Approved Zembrace® SymTouch® to Treat Migraines - StockTitan

Sep 27, 2024
pulisher
Sep 25, 2024

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Decline in Short Interest - Defense World

Sep 25, 2024
pulisher
Sep 25, 2024

Tonix Pharm stock plunges to 52-week low of $0.13 By Investing.com - Investing.com Australia

Sep 25, 2024
pulisher
Sep 24, 2024

Tonix Pharm stock plunges to 52-week low of $0.13 - Investing.com

Sep 24, 2024
pulisher
Sep 23, 2024

Tonix Pharmaceuticals advances fibromyalgia treatment - Investing.com

Sep 23, 2024
pulisher
Sep 23, 2024

Technical analysis of Tonix Pharmaceuticals Holding Corp (TNXP) stock chart patterns - US Post News

Sep 23, 2024
pulisher
Sep 23, 2024

Tonix Pharma Highlights TNX-102 SL at Global Pharmaceutics Conference - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Balance Sheet Insights: Tonix Pharmaceuticals Holding Corp (TNXP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 23, 2024
pulisher
Sep 23, 2024

Tonix Pharmaceuticals announces data presentations on TNX-102 SL - TipRanks

Sep 23, 2024
pulisher
Sep 23, 2024

Tonix Pharmaceuticals advances fibromyalgia treatment By Investing.com - Investing.com UK

Sep 23, 2024
pulisher
Sep 23, 2024

Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global Conference on Pharmaceutics and Novel Drug Delivery Systems (PDDS 2024) - StockTitan

Sep 23, 2024
pulisher
Sep 20, 2024

Tonix Pharmaceuticals files $300M mixed securities shelf - TipRanks

Sep 20, 2024
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):